ResMed Inc. (RMD) 12-Month Stock Forecast & Price Target Cone
ResMed Inc. (RMD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (59% profit margin, 23% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Drag to Test Your RMD Position Size: $10,000
Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)
Street Historical Accuracy: 64/100| Wall Street Firm | Stance | 12M Target | 1Y Accuracy | Track Grade |
|---|---|---|---|---|
| Morgan StanleyInstitutional Equity Desk | OUTPERFORM | $282 | 74% | A |
| Goldman SachsSector Coverage Lead | STRONG BUY | $301 | 69% | B |
| JP MorganUS Large-Cap Research | HOLD | $239 | 58% | C |
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live RMD Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on RMD today. View full Setup Ledger →
RMD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhat is RMD's 12-month stock price target?
ResMed Inc. (RMD) carries a 12-month consensus base price target of $271.03 (+7.2% from $252.83), with a bull-case target of $319.82 and a bear-case floor of $207.32.
Is RMD stock a Buy, Hold, or Sell right now?
Roarable's 5-Pillar RQD Quant Engine rates RMD B (Buy — BUY) with an RQD Confidence score of 74/100.